6CORRETTI M C,ANDERSON T J,BENJAMIN E J,et al.Guidelines for the ultrasound assessment of endothelial dependent flow-mediatet vasodilation of the brachial artery[J].J Am Coll Cardiol,2002,39:257-265.
7JEAN D.Beneficial cardiovascular pleiotropic effects of statins[J].Circulation,2004,109:III39-43.
8LEU H B,WU C C,WU T C,et al.Fluvastatin reduces oxidative stress,decreases serum monocyte chemotactic protein-1 level and improves endothelial function in patients with hypercholesterolemia[J].J Formos Med Assoc,2004,103:914-920.
9KOH K K,QUON M J,HANS H,et al.Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients[J].Diabetes Care,2008,31:776 -782.
10LAUFS U,LA FATA V,PLUTZKY J,et al.Upregulation of endothelial nitric oxide synthase by HMG COA reductase inhibitors[J].Circulation,1998,97:1129-1135.
8Rebecca Rudominer Ascunee,Jeffrey S. Berger, Howard S. Weintraub,et al. The Role of Statin Therapy for Pri- mary Prevention: What is the Evidence ?[J]. Current Atherosclerosis Reports, 2012,14(2) : 167- 174.
9Qian Zhou, James K Liao. Pleiotropic effects of statins- basic research and clinical perspectives [J]. Circulation Journal : Official Journal of the Japanese Circulation Soci- ety,2010,74 (5) :818-826 .
10Chapman MJ. Review: Fibrates: therapeutic review [J]. British Journal of Diabetes : Vascular Disease, 2006,6(1):11-19.
